(Reuters) Innoviva Inc said activist investor Sarissa Capital Management LP had nominated four directors to replace a majority of the drug company’s board.
The company’s shares were up 3.1 percent at $12 in early trading on Tuesday.
Innoviva, formerly Theravance Inc, urged shareholders to vote for its recommended seven nominees at the 2017 annual meeting.
To read this article, click here.
